Dario Expects Proprietary AI Engine DarioIQ™ to Increase Recurring Revenue from Existing Customers by 10-15%

15 hours ago

DarioIQ drives higher engagement and retention, better clinical outcomes, higher client ROI and recurring revenue growth for DarioDario IQ's AI-driven…

Cochlear introduces the new Osia® 3 Sound Processor

15 hours ago

Fully rechargeable: First fully rechargeable active bone conduction sound processor, with up to 30 hours of battery life on a…

Ultrasound-on-Chip Licensing Market to Reach USD 200.5 Million by 2036 as AI-Enabled Imaging and Embedded Ultrasound Technologies Drive Healthcare Innovation

15 hours ago

NEWARK, Del., July 13, 2026 /PRNewswire/ -- According to Future Market Insights (FMI), the global Ultrasound-on-Chip Licensing Market is projected to grow…

Hypha Labs (OTCQB:FUNI) Sees State-by-State Psilocybin Reform Creating the Next Major Growth Opportunity

15 hours ago

Company Believes Industry Is Following the Early Regulatory Path That Fueled the Cannabis Market LAS VEGAS, NV / ACCESS Newswire…

Glioblastoma Foundation Marks 10 Years with New Push to Accelerate Personalized Treatment

15 hours ago

As glioblastoma continues to challenge the medical community, the Foundation unveils a new genomic testing lab, an advancing drug pipeline,…

Rejuvenate Muscle Health(TM) Expands its Position in the Emerging GLP-1 Muscle Health Category with U.S. Pharmacy Program and National E-Commerce Expansion

16 hours ago

Top-tier U.S. grocery and pharmacy chain launches 662-store GLP-1 pharmacy merchandisingOne of North America's largest omnichannel retailers approves onboarding of…

WELL Health Announces Pricing of $150 Million Senior Unsecured Notes Offering

16 hours ago

WELL has priced its inaugural offering of $150 million of senior unsecured notes due 2031, bearing interest at 6.875% per…

Nanografi Increases Click-Through Rates and Scientific Engagement With Bioz

18 hours ago

PALO ALTO, CA / ACCESS Newswire / July 13, 2026 / Bioz, the company transforming scientific publications into product credibility,…

New Phase 1 Data Show VNA-318 Mechanism of Action Translates to Humans, Supporting Potential to Address Medical Needs of People with Neurodegenerative Diseases

18 hours ago

Pharmacodynamic effects in the human brain and energy metabolism biomarker data presented at AAIC support further clinical development of VNA-318…

Genflow Biosciences PLC Announces Mid-Year Operational and Corporate Summary

21 hours ago

LONDON, UK / ACCESS Newswire / July 13, 2026 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or the "Company"), an emerging…